Skip to content

SHAZ SHAZ Gains Losses On Warrants

Gains Losses On Warrants at other companies

NewAmsterdam Pharma Company logo
NewAmsterdam Pharma CompanyNAMS
-$5.94M+56.8%
NextNav logo
NextNavNN
$12.61M+168%
Cinemark Holdings logo
Cinemark HoldingsCNK
$0
Banc of California logo
Banc of CaliforniaBANC
$938K+418%
General Purpose Acquisition Corp.
 logo
General Purpose Acquisition Corp. GPAC
$667.57K+139%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$0+100%

Other financials

Income statement

See full
Revenue$294.0K-9.6%
Gross profit-$231.8K-2,080%
Operating income-$2.8M-143%
Net income-$19.9M-1,290%
EPS (diluted)-$1.43-6.7%

Balance sheet

See full
Cash & equivalents$164.3M+5,675%
Total debt$6.0M
Total equity$88.6M+207%
Total assets$313.9M

Cash flow

See full
Operating cash flow-$7.4M-461%
CapEx$66.7K+102%
Free cash flow-$7.5M-452%

Valuation

See full
Market cap$1.4B
Enterprise value$1.24B
P/S1,671.7×

Profitability

See full
Gross margin-30.5%
Operating margin-639.9%
Net margin-667.1%
FCF margin-799.3%

Returns & leverage

See full
Return on equity-26.1%
Debt / equity0.1×
Current ratio

Where this comes from

Reported directly by SHAZ in its filing.

Tagged under the XBRL concept SHAZ:GainsLossesOnWarrants.

The official record: SHAZ’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about SHAZ's gains losses on warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SHAZ's gains losses on warrants?
SHAZ (SHAZ) reported gains losses on warrants of $111.25K in Q4 2025.
What does gains losses on warrants mean?
Reflects the changes in the fair value of outstanding warrants issued by the company, typically recognized as non-operating income or expense. Fluctuations in this metric are often driven by changes in the company's underlying stock price and the remaining term of the warrants. It provides insight into the potential dilution and financial impact of derivative instruments on the company's bottom line.